Transaction in Own Shares

By

Regulatory News | 22 Oct, 2024

Updated : 07:01

RNS Number : 0082J
Litigation Capital Management Ltd
22 October 2024
 

22 October 2024

Litigation Capital Management Limited

("LIT", the "Company" or the "Group")

Transaction in Own Shares

 

The Company announces that Canaccord Genuity Limited ("Canaccord") has made the following purchases of ordinary shares of no par value in the capital of the Company ("Ordinary Shares"), on its behalf on the London Stock Exchange, pursuant to the Share Buyback Programme announced on 5 October 2023.

Date of purchase

21 October 2024

Number of Ordinary Shares purchased (aggregated volume):

60,000

Highest Price paid per Ordinary Share (p):

108

Lowest Price paid per Ordinary Share (p):

108

Volume Weighted Average Price paid per Ordinary Share (p):

108

Venue where Ordinary Shares are traded

London Stock Exchange (AIM)

Canaccord holds the repurchased shares on behalf of the Company. Following the purchase, the number of Ordinary Shares in issue and admitted to trading on AIM will be 114,629,431 excluding shares held by Canaccord (being the "Total Share Capital"). Canaccord on behalf of the Company will hold 4,570,901 ordinary shares, representing approximately 3.99% per cent of the Total Share Capital.

 

This figure of 114,629,431 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

The Company and Canaccord will make further announcements in due course following the completion of any further purchases pursuant to the Share Buyback Programme.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the purchases made by Canaccord on behalf of the Company.

Individual transactions:

Number of shares purchased

Transaction price (pence per share)

Time of transaction

Trading venue

60,000

108

15:14:44

London Stock Exchange

 

Enquiries

 

Litigation Capital Management

c/o Tavistock

Patrick Moloney, Chief Executive Officer

David Collins, Chief Financial Officer

 


 

Cavendish (Nomad and Joint Broker)  

Tel: 020 7220 0500

Jonny Franklin-Adams and Rory Sale (Corporate Finance)

Tim Redfern and Jamie Anderson (Corporate Broking) 




Canaccord Genuity (Joint Broker) 

Tel: 020 7523 8000

Bobbie Hilliam


 


Tavistock (PR and IR)

Tel: 020 7920 3150

Katie Hopkins

Simon Hudson

lcm@tavistock.co.uk



 

NOTES TO EDITORS

Litigation Capital Management (LCM) is an alternative asset manager specialising in disputes financing solutions internationally, which operates two business models. The first is direct investments made from LCM's permanent balance sheet capital and the second is third party fund management. Under those two business models, LCM currently pursues three investment strategies: Single-case funding, Portfolio funding and Acquisitions of claims. LCM generates its income from both its direct investments and also performance fees through asset management.

 

LCM has an unparalleled track record driven by disciplined project selection and robust risk management. Currently headquartered in Sydney, with offices in London, Singapore, Brisbane and Melbourne, LCM listed on AIM in December 2018, trading under the ticker LIT.

 

www.lcmfinance.com

  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSEFLFLZBLXFBF

Last news